(Q36429393)

14 August 2017

1 reference

title

3p21.3 tumor suppressor cluster: prospects for translational applications (English)

1 reference

14 August 2017

Lin Ji

1

1 reference

14 August 2017

John D Minna

series ordinal

2

1 reference

14 August 2017

Jack A Roth

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

79-92

1 reference

14 August 2017

1

1 reference

14 August 2017

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Dynamics of cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

A census of human cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Making the most of microarray data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Cancer: understanding the target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Chromosome 3p and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Genetic and epigenetic changes in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

A phylogenetic study of cytochrome b561 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Somatic selection for and against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Genomic instability--the engine of tumorigenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Three classes of genes mutated in colorectal cancers with chromosomal instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Prevalence of somatic alterations in the colorectal cancer cell genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Principles of tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The six hyaluronidase-like genes in the human and mouse genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

A G-to-A single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene that maps at chromosome 3p21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Modulation of sciatic nerve expression of class 3 semaphorins by nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Identification of semaphorin3B as a direct target of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of Hyal1 with downstream genes, Fus2 and Hyal3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Expression and activity of hyaluronidase in human periodontal ligament fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Modeling human lung cancer in mice: similarities and shortcomings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The genetics and genomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology and is associated with the expression of a truncated alpha 2 delta-2 protein with abnormal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

entla, a novel epileptic and ataxic Cacna2d2 mutant of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Control of microtubule stability by the RASSF1A tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.1.79

21 January 2018

Identifiers

DOI

10.1517/14796694.1.1.79

1 reference

14 August 2017

1 reference